500 results on '"Houghton, Alan N."'
Search Results
2. Immunization of Metastatic Breast Cancer Patients with a Fully Synthetic Globo H Conjugate: A Phase I Trial
3. Induction of Cellular Immunity by Immunization with Novel Hybrid Peptides Complexed to Heat Shock Protein 70
4. Supplementary Figure Legend from GITR Pathway Activation Abrogates Tumor Immune Suppression through Loss of Regulatory T-cell Lineage Stability
5. Data from GITR Pathway Activation Abrogates Tumor Immune Suppression through Loss of Regulatory T-cell Lineage Stability
6. Supplementary Figure 1 from GITR Pathway Activation Abrogates Tumor Immune Suppression through Loss of Regulatory T-cell Lineage Stability
7. Supplementary Figure 2 from GITR Pathway Activation Abrogates Tumor Immune Suppression through Loss of Regulatory T-cell Lineage Stability
8. Data from Peptide-Loaded Langerhans Cells, Despite Increased IL15 Secretion and T-Cell Activation In Vitro, Elicit Antitumor T-Cell Responses Comparable to Peptide-Loaded Monocyte-Derived Dendritic Cells In Vivo
9. Supplementary Figures S1-S3 from Peptide-Loaded Langerhans Cells, Despite Increased IL15 Secretion and T-Cell Activation In Vitro, Elicit Antitumor T-Cell Responses Comparable to Peptide-Loaded Monocyte-Derived Dendritic Cells In Vivo
10. Supplementary Figure 3 from Immune Rejection of Mouse Tumors Expressing Mutated Self
11. Data from Immune Rejection of Mouse Tumors Expressing Mutated Self
12. Supplementary Figure 4 from Immune Rejection of Mouse Tumors Expressing Mutated Self
13. Data from Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment
14. Supplementary Figure 1 from Immune Rejection of Mouse Tumors Expressing Mutated Self
15. Supplementary Figures 1-3 from Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment
16. Supplementary Figure Legends 1-4 from Immune Rejection of Mouse Tumors Expressing Mutated Self
17. Supplementary Figure 2 from Immune Rejection of Mouse Tumors Expressing Mutated Self
18. Immune Response to a Differentiation Antigen Induced by Altered Antigen: A Study of Tumor Rejection and Autoimmunity
19. A Perspective on Cancer Immunology and Immunotherapy
20. Abstract 4167: Combination of cyclophosphamide with immune checkpoint blockade inhibition elicits potent tumor control in a preclinical melanoma model
21. A T Cell Receptor Associated with Naturally Occurring Human Tumor Immunity
22. Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs
23. Cyclophosphamide enhances the antitumor potency of GITR engagement by increasing oligoclonal cytotoxic T cell fitness
24. Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation
25. Development of effective vaccines for old mice in a tumor model
26. Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses
27. Specificity Analysis of Human Monoclonal Antibodies Reactive with Cell Surface and Intracellular Antigens
28. Mouse Monoclonal IgG3 Antibody Detecting G D3 Ganglioside: A Phase I Trial in Patients with Malignant Melanoma
29. Loss of Polymorphic Restriction Fragments in Malignant Melanoma: Implications for Tumor Heterogeneity
30. Serological Survey of Normal Humans for Natural Antibody to Cell Surface Antigens of Melanoma
31. Homozygous Deletions within Human Chromosome Band 9p21 in Melanoma
32. Generation of Human Monoclonal Antibodies Reactive with Cellular Antigens
33. Intracellular Sorting and Targeting of Melanosomal Membrane Proteins: Identification of Signals for Sorting of the Human Brown Locus Protein, GP75
34. Cell Surface Antigens of Human Astrocytoma Defined by Mouse Monoclonal Antibodies: Identification of Astrocytoma Subsets
35. Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopes
36. Autoimmunity and tumor immunity induced by immune responses to mutations in self
37. Optimization of a self antigen for presentation of multiple epitopes in cancer immunity
38. FAPα, a surface peptidase expressed during wound healing, is a tumor suppressor
39. Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity
40. Molecular Biology of Melanoma
41. List of Contributing Authors
42. Unraveling the Complex Relationship Between Cancer Immunity and Autoimmunity: Lessons from Melanoma and Vitiligo
43. The role of the immune system in early epithelial carcinogenesis: B-ware the double-edged sword
44. Immunity to Cancer Through Immune Recognition of Altered Self: Studies with Melanoma
45. DNA-Based Cancer Vaccines
46. Cell-Mediated Immunity to Cancer
47. Phase Ii Study of Temozolomide and Thalidomide in Patients With Metastatic Melanoma in the Brain: High rate of thromboembolic events (CALGB 500102)
48. Phase II study of temozolomide plus pegylated interferon-α-2b for metastatic melanoma
49. Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma
50. Mapping effector functions of a monoclonal antibody to GD3 by characterization of a mouse-human chimeric antibody
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.